Q2 FY26 results: revenue flat, profit steady, margins under pressure
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 0.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Lotus Eye Hospital reported Q2 FY26 revenue of Rs 1,303.84 lakhs, nearly flat YoY versus Rs 1,291.24 lakhs. H1 FY26 revenue grew modestly to Rs 2,655.53 lakhs. Net profit for H1 FY26 stood at Rs 9.42 lakhs vs Rs 8.82 lakhs last year. Exceptional items of Rs 79.95 lakhs (H1) from PPE sale boosted pre-tax profits. EBITDA margins shrank from about 13% to 10% YoY, reflecting higher costs. Auditor issued a clean limited review report.
Flat revenue and shrinking margins signal cost pressure; exceptional PPE sale lifted headline profit. Watch for margin recovery in coming quarters.